
Global Cord Blood Corporation CO
Geschäftsbericht 2022
hinzugefügt 16.08.2022
Global Cord Blood Corporation EV 2011-2026 | CO
EV Jährlich Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.77 B | -2.07 B | -1.78 B | -1.05 B | -409 M | 385 M | 422 M | 600 M | 622 M | 457 M | 11.5 M | 95.1 M |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 622 M | -2.77 B | -457 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 19.02 | 0.21 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 20.15 | -2.3 % | $ 217 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.17 | -6.7 % | $ 4.99 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 228.92 | -0.76 % | $ 167 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
DexCom
DXCM
|
52.4 B | $ 66.37 | -1.03 % | $ 25.6 B | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.53 | 2.0 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 38.9 | -1.04 % | $ 1.08 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 11.38 | 6.36 % | $ 323 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 225.41 | -1.0 % | $ 40.9 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.56 | -0.33 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 26.27 | -0.83 % | $ 794 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 18.84 | -1.21 % | $ 1.01 B | ||
|
Celcuity
CELC
|
506 M | $ 99.74 | -0.18 % | $ 3.93 B | ||
|
Myriad Genetics
MYGN
|
1.2 B | $ 6.15 | -0.32 % | $ 557 M | ||
|
NeoGenomics
NEO
|
1.9 B | $ 11.76 | -3.84 % | $ 1.49 B | ||
|
National Research Corporation
NRC
|
1.08 B | $ 18.77 | 0.64 % | $ 461 M | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.12 | - | $ 99.5 K | ||
|
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 27.08 | -1.13 % | $ 20 B | ||
|
Precipio
PRPO
|
10.9 M | $ 22.98 | -1.84 % | $ 29.8 M | ||
|
Personalis
PSNL
|
229 M | $ 7.96 | -0.13 % | $ 472 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | $ 44.97 | -0.77 % | $ 10 B | ||
|
Guardant Health
GH
|
6.94 B | $ 102.14 | 1.53 % | $ 12.5 B | ||
|
RadNet
RDNT
|
5.09 B | $ 71.35 | -0.2 % | $ 5.21 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Soleno Therapeutics
SLNO
|
1.95 B | $ 46.3 | 0.02 % | $ 1.86 B | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 4.53 | -4.83 % | $ 2.43 M | ||
|
Illumina
ILMN
|
15.3 B | $ 131.16 | -1.2 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 199.48 | -1.24 % | $ 10.2 B | ||
|
Thermo Fisher Scientific
TMO
|
202 B | $ 579.45 | -0.69 % | $ 221 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.79 | -3.54 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 31.72 | -1.34 % | $ 1.9 B | ||
|
Quidel Corporation
QDEL
|
460 M | $ 28.56 | -2.53 % | $ 1.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 173.53 | -1.12 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
142 M | $ 6.8 | 1.19 % | $ 882 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K |